| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $35,134,954 ) (Continued on the next page) |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NR021134 | Maternal OutcoMes (MOMs) Program: Testing Integrated Maternal Care Model Approaches to Reduce Risk of Severe Maternal Morbidity | 000 | 3 | NIH | 7/24/2025 | $805,554 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL153810 | Influencing Basic Behavioral Mechanisms of Action while targeting Daily Walking in Those at Risk for Cardiovascular Disease: Science of Behavior Change Factorial Experiment of Behavioral Change | 001 | 5 | NIH | 8/12/2025 | $720,481 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 003 | 7 | NIH | 5/29/2025 | $41,875 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 002 | 7 | NIH | 3/26/2025 | $376,875 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K08AI193352 | Comparison of the Dysregulated and Regulated Host Responses to Infection | 000 | 1 | NIH | 8/5/2025 | $162,000 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P01AI073693 | Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | 003 | 16 | NIH | 6/18/2025 | $123,116 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P01AI073693 | Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | 001 | 16 | NIH | 5/7/2025 | $2,383,008 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R03CA293119 | Understanding the communication between cancer cells and cancer-associated fibroblasts in chronic lymphocytic leukemia: roles clarification and therapeutic targets exploration | 000 | 1 | NIH | 7/30/2025 | $167,500 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH140013 | Vital Signs for Psychosis: Personalized Longitudinal Markers of Psychosis Severity Using Automated Speech and Language Analysis | 000 | 1 | NIH | 7/23/2025 | $845,163 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P01MH139136 | Early-Phase Psychosis: Practice-Based Research to Improve Treatment Outcomes | 000 | 1 | NIH | 6/2/2025 | $1,659,568 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UH3OD035532 | The Environmental Factors in FEtal to Childhood Trajectories Cohort | 000 | 3 | NIH | 6/5/2025 | $5,565,420 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AI193493 | MSP68 as an effective radiation countermeasure | 000 | 1 | NIH | 7/3/2025 | $167,500 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23DK132459 | Using Digital Solutions to Improve Transition of Care for Patients with Acute Kidney Injury | 000 | 4 | NIH | 2/19/2025 | $191,853 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH136489 | Sex dependent dysregulation of parvalbumin interneurons as a pathway to Autism Spectrum Disorder | 000 | 2 | NIH | 8/6/2025 | $209,375 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35HL171168 | Cellular and Molecular Control of Normal and Disordered Erythropoiesis | 000 | 2 | NIH | 1/28/2025 | $853,132 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U01AI170018 | Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures | 000 | 4 | NIH | 6/26/2025 | $767,178 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R33MH123574 | Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk in Adolescents at Clinical High Risk for Psychosis | 000 | 5 | NIH | 5/22/2025 | $665,809 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH117646 | Cognitive Genomics as a Window on Neurodevelopment and Psychopathology | 000 | 7 | NIH | 12/9/2024 | $536,398 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U19AI144306 | A mechanistic understanding of B cell and macrophage plasticity in lupus disease activity states | 002 | 7 | NIH | 8/11/2025 | $779,404 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH137681 | 4/5-Clinical Outcome Prediction of Psychosis from EHRs (COPPER) | 001 | 2 | NIH | 7/18/2025 | $480,834 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 000 | 16 | NIH | 12/19/2024 | $487,376 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 001 | 16 | NIH | 8/5/2025 | $54,153 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH134883 | 2/5-Biomarkers to Enhance Early Schizophrenia Treatment (BEEST) | 001 | 2 | NIH | 8/7/2025 | $630,879 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23HL163498 | Leveraging Heath Information Technology to Improve Post-Discharge Management for Patients with Heart Failure | 000 | 3 | NIH | 5/17/2025 | $192,988 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | S10OD036216 | Acquisition of high-parameter fluorescent-activated cell sorter analyzer | 001 | 1 | NIH | 7/7/2025 | $250,000 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | S10OD036216 | Acquisition of high-parameter fluorescent-activated cell sorter analyzer | 001 | 1 | NIH | 7/7/2025 | -$250,000 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | S10OD036216 | Acquisition of high-parameter fluorescent-activated cell sorter analyzer | 000 | 1 | NIH | 6/5/2025 | $689,031 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 000 | 3 | NIH | 1/14/2025 | $10,000 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 000 | 3 | NIH | 1/14/2025 | $20,000 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AR083159 | Brain neural networks regulating inflammation | 000 | 3 | NIH | 8/1/2025 | $549,581 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AG076888 | Increasing Meaning to Reduce Loneliness in Care Partners of Persons with AD/ADRD | 000 | 4 | NIH | 6/18/2025 | $123,449 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH137501 | Cerebellar-Cortical Circuitry and Treatment Response in Early Psychosis | 000 | 1 | NIH | 6/6/2025 | $519,558 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UH3OD035513 | Developmental Impact of NICU Exposures (DINE) phase II | 000 | 3 | NIH | 6/5/2025 | $837,445 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AG078496 | Tau networks in AD psychosis | 000 | 4 | NIH | 6/26/2025 | $106,439 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NR020774 | Optimization of monitoring, prediction and phenotyping of deterioration of inhospital patients using machine learning and multimodal real time data | 000 | 3 | NIH | 6/17/2025 | $800,320 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AG087104 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD) | 000 | 1 | NIH | 6/2/2025 | $852,049 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM145331 | Mechanisms of Dysregulated Innate Immune Responses to Lethal Infections | 001 | 4 | NIH | 8/14/2025 | $418,750 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA260691 | Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma | 001 | 5 | NIH | 8/15/2025 | $1,064,245 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01GM137203 | Preoperative exercise therapy modulates hepatic neutrophil extracellular trap formation | 000 | 5 | NIH | 12/4/2024 | $84,018 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R24AG064191 | Roybal Resource and Coordinating Center to Accelerate Translational Aging Research | 003 | 7 | NIH | 4/26/2025 | $74,067 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R24AG064191 | Roybal Resource and Coordinating Center to Accelerate Translational Aging Research | 002 | 7 | NIH | 4/21/2025 | $666,618 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL139778 | Therapeutic Potential of ALK1 Activating Drugs in HHT Models | 000 | 5 | NIH | 12/31/2024 | $569,892 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM118337 | Novel Approaches to Maintaining Organ Function in Sepsis | 001 | 9 | NIH | 6/26/2025 | $508,781 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 002 | 3 | NIH | 8/5/2025 | $73,970 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 000 | 3 | NIH | 3/10/2025 | $665,742 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 001 | 3 | NIH | 4/4/2025 | $0 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AA023146 | Role of Beta Spectrin and Smad in Alcohol-Induced Liver and GI Cell Proliferation | 000 | 19 | NIH | 7/29/2025 | $443,383 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Advancing Cardiothoracic Surgical Trials in Rural Health Populations | 002 | 7 | NIH | 8/12/2025 | $52,292 |
| | 2025 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Advancing Cardiothoracic Surgical Trials in Rural Health Populations | 001 | 7 | NIH | 2/26/2025 | $470,622 |
|
